Convegni
L'Associazione Italiana Ricerca Patologie Polmonari organizza e prende parte ogni anno a diversi Convegni e Congressi nazionali e internazionali nell'ambito delle Patologie Polmonari e della Ricerca Scientifica.

Malignant pleural mesothelioma: the strength of collaboration behind successful research and clinical management
Il mesotelioma maligno della pleura è la neoplasia più frequente della pleura, correlata da un punto di vista eziopatogenetico all'esposizione alle fibre di asbesto (amianto). Nonostante i passi avanti nello studio dei meccanismi di insorgenza di tale neoplasia, la prognosi rimane infausta, soprattutto in relazione al fatto che la diagnosi sopraggiunge spesso tardivamente e che la terapia non risulta sempre efficace.
Live Webinar online 01-07-2021
II International Symposium: AMR and BEYOND - Antibody-mediated rejection in lung transplantation: let’s work through difficult cases together
Pulmonary antibody mediated rejection (AMR) after lung transplantation is an
important cause of acute and chronic allograft dysfunction. It is critical that the lung
transplant clinician, pathologist and immunologist have a strong understanding of the
criteria for the diagnosis and assessment of AMR and of the approaches used to
manage these patients. Understanding the clinical, pathological and immunological
features of AMR will help to close the practice gap in specialist knowledge. We are
delighted to offer for the second time this interactive educational opportunity to
update the knowledge in this complex diagnostic scenario.
The interactive symposium is aimed at experienced lung transplant specialists
(Pulmonologists/Respirologists, Surgeons, Pathologists, Immunologists) that should
routinely work in a multidisciplinary team for a more sensitive and accurate diagnosis
and appropriate management of this complication.
Live Webinar online at www.overgroup.eu 01-12-2020
II International Symposium: AMR and BEYOND - Antibody-mediated rejection in lung transplantation: how manage and treat patients?
Pulmonary antibody mediated rejection (AMR) after lung transplantation is an
important cause of acute and chronic allograft dysfunction. It is critical that the lung
transplant clinician, pathologist and immunologist have a strong understanding of the
criteria for the diagnosis and assessment of AMR and of the approaches used to
manage these patients. Understanding the clinical, pathological and immunological
features of AMR will help to close the practice gap in specialist knowledge. We are
delighted to offer for the second time this interactive educational opportunity to
update the knowledge in this complex diagnostic scenario.
The interactive symposium is aimed at experienced lung transplant specialists
(Pulmonologists/Respirologists, Surgeons, Pathologists, Immunologists) that should
routinely work in a multidisciplinary team for a more sensitive and accurate diagnosis
and appropriate management of this complication.
Live Webinar online at www.overgroup.eu 17-11-2020